FDA inspection
Acadia Pharmaceuticals Inc.: FDA inspection ending Feb 17, 2016
FDA inspection 965150 · Voluntary Action Indicated (VAI) · San Diego, CA
Key facts
| Inspection ID | 965150 |
|---|---|
| Firm | Acadia Pharmaceuticals Inc. |
| FEI number | 3005617555 |
| Address | 3611 Valley Centre Dr Ste 300 |
| City | San Diego |
| State | CA |
| ZIP | 92130 |
| Country | United States |
| Fiscal year | 2016 |
| Inspection end date | Feb 17, 2016 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data